Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro

Tumor Biology

Volumn 34, Issue 4, 2013, Pages 2409-2418

  Liu, Ying ^a   Zhu, Zu An ^a   Zhang, Shang Nuan ^a   Mou, Jie ^a   Liu, Lei ^a   Cui, Tao ^a   Pei, Dong Sheng ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

9 cis RA; PPAR ; RXR; SGC7901; TGZ

Indexed keywords

ALITRETINOIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEIN BAX; PROTEIN BCL 2; RETINOID X RECEPTOR GAMMA; TROGLITAZONE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; UPREGULATION; WESTERN BLOTTING;

EID: 84881478784     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0791-2     Document Type: Article

References (22)

1. Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol. 1996;12:335-63. doi: 10.1146/annurev.cellbio.12.1.335.
2. Leung WK, Bai AH, Chan VY, et al. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. Gut. 2004;53:331-8. doi: 10.1136/gut.2003.021105.
3. Pitulis N, Papageorgiou E, Tenta R, et al. IL-6 and PPAR gamma signalling in human PC-3 prostate cancer cells. Anticancer Res. 2009;29:2331-7.
4. Moon HS, Guo DD, Lee HG, et al. Alpha-eleostearic acid suppresses proliferation of MCF-7 breast cancer cells via activation of PPAR gamma and inhibition of ERK 1/2. Cancer Sci. 2010;101:396-402. doi: 10.1111/j.1349-7006. 2009.01389.x.
5. Shimada T, Kojima K, Yoshiura K, et al. Characteristics of the peroxisome proliferator activated receptor gamma (PPAR gamma) ligand induced apoptosis in colon cancer cells. Gut. 2002;50:658-64. doi: 10.1136/gut.50.5.658.
6. Krishnan A, Nair SA, Pillai MR. Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr Mol Med. 2007;7:532-40.
7. Sarraf P, Mueller E, Smith WM, et al. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell. 1999;3:799-804. doi: 10.1016/S1097-2765(01)80012-5.
8. Ikezoe T, Miller CW, Kawano S, et al. Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies. Cancer Res. 2001;61:5307-10.
9. Galli A, Mello T, Ceni E, et al. The potential of antidiabetic thiazolidinediones for anticancer therapy. Expert Opin Investig Drugs. 2006;15:1039-49. doi: 10.1517/13543784.15.9.1039.
10. Shimizu M, Moriwaki H. Synergistic effects of PPAR gamma ligands and retinoids in cancer treatment. PPAR Res. 2008;2008:181047. doi: 10.1155/2008/181047.
11. Lotan Y, Xu XC, Shalev M, et al. Differential expression of nuclear retinoid receptors in normal and malignant prostates. J Clin Oncol. 2000;18:116-21.
12. Brabender J, Metzger R, Salonga D, et al. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis. 2005;26:525-30. doi: 10.1093/carcin/bgi006.
13. Chakravarti N, Lotan R, Diwan AH, et al. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res. 2007;13:4817-24. doi: 10.1158/1078-0432.CCR-06-3026.
14. Knapp P, Jarzabek K, Błachnio A, et al. The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis. Ginekol Pol. 2006;77:643-51.
15. Clarke N, Germain P, Altucci L, et al. Retinoids: potential in cancer prevention and therapy. Expert Rev Mol Med. 2004;6:1-23. doi: 10.1017/S1462399404008488.
16. Konopleva M, Elstner E, McQueen TJ, et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Mol Cancer Ther. 2004;3:1249-62.
17. Kato M, Kusumi T, Tsuchida S, et al. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone. J Cancer Res Clin Oncol. 2004;130:73-9. doi: 10.1007/s00432-003-0510-2.
18. Hu W, Xue-yan Y, Shi-guo Z, et al. Effects of 9-cis2 retinoic acid on transcription of retinoic acid receptors RXR in lung cancer cells. Mol Cardiol China. 2004;01:16-20.
19. Zhu L, Gong B, Bisgaier CL, et al. Induction of PPAR gamma1 expression in human THP-1 monocytic leukemia cells by 9-cis-retinoic acid is associated with cellular growth suppression. Biochem Biophys Res Commun. 1998;251:842-8. doi: 10.1006/bbrc.1998.9567.
20. Wolter KG, Hsu YT, Smith CL, et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139:1281-92. doi: 10.1083/jcb.139.5.1281.
21. Lin CF, Chen CL, Chang WT, et al. Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation. J Biol Chem. 2005;280:23758-65. doi: 10.1074/jbc.M412292200.
22. Xie Z, Koyama T, Suzuki J, et al. Coronary reperfusion following ischemia: different expression of bcl-2 and bax protein, and cardiomyocyte apoptosis. Jpn Heart J. 2001;42:759-70. doi: 10.1536/jhj.42.759.